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Breast cancer epidemiology in young women 
 
Epidemiologija raka dojke kod mladih žena 
 




Breast cancer is the most common malignancy in the population of women. Among young women, breast 
cancer incidence is 5-18% throughout different countries of the world. Young age for the appearance of breast 
cancer in woman is considered to be under 40 years of age. We wanted to research the epidemiologic data and 
incidence of breast cancer in a population of young women. This was a retrospective study. Data were gathered 
from medical documentation in the Department of Surgery of Clinical Hospital Centre Osijek. The total 
number of patients operated with breast cancer was (N = 1654) in period 2004-2011. Out of this number 71 
(4.29 %) were < 40 years and 1583 (95.71%) were ≥ 40 years. The incidence trend in young women seems to 
be stable. Breast cancer incidence in the general population is increasing according to the National 
mammographic screening program. 





Rak dojke je najčešća maligna bolest u ženskoj populaciji. Učestalost raka dojke među mladim ženama je 
5-18% na svjetskoj razini. Mladom ženom, s obzirom na karcinom dojke, smatra se žena mlađa od 40 godina. 
Željeli smo istražiti epidemiološke podatke i učestalost karcinoma dojke u populaciji mladih žena. Ovo je bila 
retrospektivna studija. Podaci su prikupljeni iz medicinske dokumentacije na Odjelu za kirurgiju, Kliničkog 
bolničkog centra Osijek. Ukupan broj bolesnica s karcinomom dojke koje su operirane, bio je (N = 1654) u 
razdoblju od 2004. do 2011. godine. Od ovoga broja 71 (4,29%) je imao < 40 godina, a 1583 (95,71%) ≥ 40 
godina. Čini se da je trend pojavnosti kod mladih žena stabilan. Učestalost karcinoma dojke u općoj populaciji 
raste zbog Nacionalnog mamografskog programa probira. 






Breast cancer is the most common malignancy in 
the population of women and one of the leading causes 
of worldwide mortality in general.1-3 It is rather rare 
among the population of young women but, 
nevertheless, the most common malignancy. Young 
age for the appearance of breast cancer in woman is 
considered to be under 40 years of age. Breast cancer 
among young women population is considered to be 
more aggressive, with distinct pathological features, 
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more positive axillary lymph nodes and poor 
prognosis.4,5 In the western countries of the world, the 
incidence of breast cancer in this population of women 
is 5-7%. This incidence is stable, without significant 
deviation.2-4 The Chinese authors define young women 
under the age of 35 years, with an incidence twice 
higher than in the western countries at level 10-18%, 
and increasing cancer growth in the past twenty years.6 
About 2300 new breast carcinoma are diagnosed every 
year in Croatia (100/ 100.000) and more than 800 
women die due to this cancer.7 Since 2006, Croatia 
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adopted a national plan of early detection and prevention 
of breast cancer. Women between 50 and 69 years of 
age are undergoing mammographic screening.8 
Our research is aimed to explore the epidemiologic 
data of breast cancer in young women in our region and 
recent incidence trends. We wanted to explore whether 
the National Prevention Programme had an impact on 
breast cancer incidence. 
 
Materials and Methods 
 
The study design was retrospective. The data were 
gathered out of medical documentation from patients 
who underwent surgical procedure between the year 
2004 and 2011 at the Department of Surgery in KBC 
Osijek, Croatia. The patients were divided into two 
groups. The first group encompassed young women 
under 40 years of age at the time of surgery. The second 
group consisted of women aged ≥ 40 years at the time 
of surgery. All patients included in this study had positive 
pathological findings of invasive breast carcinoma. The 
number of women before and after 2007 was observed. 
Statistical analysis was performed with SPSS 13.0 
(Chicago, IL). For the comparison of patient groups, 
the Fisher exact test and χ2- test were used. The level 




The total number of patients operated with breast 
cancer was 2000 (N = 2000). 89 patients (4.45 %) 
were < 40 years and 1911 (95.55%) were ≥ 40 years 
(Table 1). 
 There was no significant difference in the number 
of women with breast cancer according to age between 
2002 to 2011. (Table 1). 
The period from 2002 to 2007 had slightly more 
respondents < 40 years, 46 (51.7%). There were 
slightly more respondents over the age of 40 in the time 
frame of 2007 to 2011, 1087 of them (56.9%), 
however, without statistically significant difference 
(Table 2). Comparing to the period between 2002-
2007, there were 263 more newly diagnosed cases of 
breast cancer in the period of 2007 to 2011 (Table 2).
 
Table 1 The distribution of patients by age 
Tablica 1. Raspodjela pacijenata prema godinama 
 
 
Number (%) of patients with breast cancer 
Broj pacijenata (%) s karcinomom dojke P* 
do 40 > 40 Total 
2002 11 (12.4) 149 (7.8) 160 (8) 
0.18 
2003 7 (7.9) 179 (9.4) 186 (9.3) 
2004 6 (6.7) 173 (9.1) 179 (9) 
2005 9 (10.1) 172 (9) 181 (9.1) 
2006 13 (14.6) 151 (7.9) 164 (8.2) 
2007 6 (6.7) 228 (11.9) 234 (11.7) 
2008 6 (6.7) 238 (12.5) 244 (12.2) 
2009 12 (13.5) 206 (10.8) 218 (10.9) 
2010 11 (12.4) 224 (11.7) 235 (11.8) 
2011 8 (9) 191 (10) 199 (10) 
Total 89 (100) 1911 (100) 2000 (100)  
 * χ2- test  
 
Table 2 The distribution of patients by age 
Tablica 2. Raspodjela pacijenata prema godinama 
  
 
Number (%) of patients with breast cancer 
Broj pacijenata (%) s karcinomom dojke 
P* 
< 40 ≥ 40 Total  
2002-2006 46 (51.7) 824 (43.1) 870 (43.5) 
0.13 
2007-2011 43 (48.3) 1087 (56.9) 1130 (56.5) 
Total/Sveukupno 89 (100) 1911 (100) 2000 (100)  
 * Fisher exact test/Fisher točno ispitivanje 





The researched period differentiated two trends 
among patient groups. Firstly, there was no significant 
change in the incidence of breast cancer in young 
women, not even after the implementation the National 
Programme in clinical practice. The second trend is the 
increased incidence of breast cancer of patients 
encompassed within the National Programme. Also, 
the decrease in incidence 4-5 years was after the first 
National Programme year. Globally, mostly in 
Western countries, the incidence of breast cancer 
increased in general but also among young women. 
This is especially significant in Spain, China, and 
Brazil.9,10 This could be explained with more organized 
mammographic screening in the older population 
worldwide. In the younger population, however, 
changes in lifestyle, a decline in fertility, and decreased 
mean age at menarche could be offered as possible 
explanations.9 In many Western countries, the 
incidence of breast cancer among young women has 
somewhat stabilized.11,12 
The increase of breast cancer incidence in Croatia 
is the product of the National Mammographic 
Screening Programme. Such results are observed in 
countries that developed similar programs. The plateau 
of incidence which is seen a few years after the target 
population was included in the mammographic 
screening is also well known. This happens because 
the pool of undiagnosed prevalent cases has reduced. 
Mammographic screening also covers carcinoma in 
situ and other pre-malignant lesions that would be 




Breast cancer incidence in the young population is 
low, 4-5%. The incidence trend in young women is 
stable.  
Breast cancer incidence in the general population is 
increasing. The National Mammographic Screening 
Program is the main reason. We can also see a plateau 
and slightly decreasing few years after a National 
Programme has been induced. 
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